Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01086800 · ClinicalTrials.gov registry record · Phase 2
Heart Biomarker Evaluation in Apnea Treatment
A Phase 2 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 318
- Enrollment target
NCT01086800 is a Phase 2 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 318 participants.
The verdict
NCT01086800, a Phase 2 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 318 participants
- Enrollment target
Study Summary
This study examines the role of sleep apnea treatment in improving cardiovascular biomarkers.
Interventions
- OTHER Healthy Lifestyles and Sleep Education plus PAP
- OTHER Healthy Lifestyles and Sleep Education plus Supplemental Oxygen
- OTHER Healthy Lifestyles and Sleep Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 318 participants |
| Start Date | 2010-02 |
| Est. Completion | 2012-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01086800
The ClinicalTrials.gov registry entry for NCT01086800 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 318 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Healthy Lifestyles and Sleep Education plus PAP is the first listed.
NCT01086800 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01086800 about?
NCT01086800 is a clinical study titled "Heart Biomarker Evaluation in Apnea Treatment". This study examines the role of sleep apnea treatment in improving cardiovascular biomarkers.
What is the current status of trial NCT01086800?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 318 participants. The study started on 2010-02. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01086800?
The interventions under investigation include: Healthy Lifestyles and Sleep Education plus PAP (OTHER), Healthy Lifestyles and Sleep Education plus Supplemental Oxygen (OTHER), Healthy Lifestyles and Sleep Education (OTHER).
Who is sponsoring clinical trial NCT01086800?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.